PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 22, 2026Investigative Ophthalmology & Visual Science0 citationsOpen Access

An APE1 Redox Inhibitor Attenuates Pathological Retinal Vascularization by Suppressing FGF2 Angiogenic Signaling

View Full Paper
CYChenfei YanQFQiang FuJWJiwen Wang

Key Points

  • The research aims to evaluate the effects of APE1 redox inhibitor Refi-10 on retinal vascularization and FGF2 signaling.
  • Assessment of APE1 and FGF2 signaling pathways
  • Evaluation of Refi-10 effects on retinal vascularization
  • Comparison of Refi-10 with VEGF inhibition
  • Refi-10 significantly attenuates pathological retinal vascularization
  • Suppression of FGF2 signaling correlates with reduced vascularization
  • Findings support APE1 and FGF2 as therapeutic targets for vascular retinopathies

Abstract

These findings nominate APE1 and FGF2 signaling as promising therapeutic targets, and show that Refi-10 holds potential as a drug candidate for vascular retinopathies, offering an alternative or complementary approach to VEGF inhibition.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Yan et al. (2026) studied this question.

synapsesocial.com/papers/69bf86ecf665edcd009e9053https://doi.org/10.1167/iovs.67.3.47
Ask AI
Helpful
Bookmark
Share
View Full Paper